COVID-19 is an emerging, rapidly evolving situation.
Get the latest public health information from CDC:

Get the latest research information from NIH: Menu
Trial record 1 of 28 for:    oxaloacetate
Previous Study | Return to List | Next Study

Trial of Oxaloacetate in Alzheimer's Disease (TOAD) (TOAD)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details. Identifier: NCT02593318
Recruitment Status : Completed
First Posted : November 1, 2015
Last Update Posted : October 12, 2018
Information provided by (Responsible Party):
Russell Swerdlow, MD, University of Kansas Medical Center

No Study Results Posted on for this Study
Recruitment Status : Completed
Actual Primary Completion Date : September 2018
Actual Study Completion Date : September 2018